THC Was the Primary Active Ingredient in Marijuana While CBC and CBD Concentrations Made No Difference
In a controlled study of 23 healthy users, varying concentrations of cannabichromene (CBC) and cannabidiol (CBD) in smoked marijuana did not change subjective, behavioral, or brain activity effects, confirming THC as the primary active constituent.
Quick Facts
What This Study Found
Twenty-three healthy marijuana users (12 men, 11 women) participated in four sessions where they smoked marijuana cigarettes under blinded conditions. Participants were assigned to low (1.8%) or high (3.6%) THC groups and received cigarettes with varying levels of CBC (0.1% vs 0.5%) and CBD (0.2% vs 1.0%).
Compared to placebo, active THC cigarettes produced expected effects on mood, behavior, and brain activity. EEG and ERP measures showed decreased performance, reduced EEG power, and attenuated attention-related ERP components during working memory and episodic memory tests.
Most effects were not dose-dependent between the two THC levels. Critically, varying the concentrations of CBC and CBD did not change any outcome measures, supporting the conclusion that THC and its metabolites are the primary active constituents of marijuana.
Key Numbers
23 participants (12 men, 11 women). Four sessions each. THC groups: 1.8% vs 3.6%. CBC: 0.1% vs 0.5%. CBD: 0.2% vs 1.0%. No dose-dependent THC effects on most measures. No CBC or CBD effects on any measures.
How They Did This
Randomized, blinded study of 23 healthy marijuana users across four sessions. Participants smoked placebo or active cigarettes with varying THC (1.8% vs 3.6%), CBC (0.1% vs 0.5%), and CBD (0.2% vs 1.0%) concentrations. Measures included subjective reports, cognitive task performance, EEG, and event-related potentials during working memory and episodic memory tasks.
Why This Research Matters
The finding that CBC and CBD concentrations did not modulate the effects of smoked marijuana challenges the "entourage effect" hypothesis at these dose levels. It also validates the use of neurophysiological measures (EEG, ERP) as biomarkers for THC effects in research settings.
The Bigger Picture
The idea that different cannabinoids interact to produce different effects (the "entourage effect") has been widely discussed. This controlled study found no evidence for CBC or CBD modulating THC effects at the concentrations tested, though the CBD levels used (0.2-1.0%) were relatively low compared to some modern cannabis products.
What This Study Doesn't Tell Us
The CBD and CBC concentrations tested were relatively low compared to some cannabis preparations. The study used only two THC dose levels that may not have been different enough to detect dose-dependent effects. The sample size was modest at 23 participants. Only acute effects were measured.
Questions This Raises
- ?Would higher CBD concentrations produce detectable modulation of THC effects?
- ?Does the entourage effect require specific cannabinoid ratios not tested here?
Trust & Context
- Key Stat:
- Varying CBC and CBD concentrations produced zero changes across all subjective, behavioral, and brain measures
- Evidence Grade:
- Randomized, blinded, placebo-controlled study with EEG/ERP biomarkers. Well-designed but modest sample size and relatively low CBD/CBC concentrations tested.
- Study Age:
- Published in 2005. Cannabis potency has increased dramatically since then, and interest in CBD and other minor cannabinoids has grown substantially.
- Original Title:
- Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.
- Published In:
- Behavioural pharmacology, 16(5-6), 487-96 (2005)
- Authors:
- Ilan, A B, Gevins, A, Coleman, M, ElSohly, M A, de Wit, H
- Database ID:
- RTHC-00193
Evidence Hierarchy
Participants are randomly assigned to treatment or placebo groups to test cause and effect.
What do these levels mean? →Frequently Asked Questions
Does CBD change the marijuana high?
At the low concentrations tested in this study (0.2-1.0% CBD), no differences were detected in any subjective, behavioral, or brain activity measure. However, modern CBD products often contain much higher concentrations than those tested here.
What is the main active ingredient in marijuana?
This study confirmed THC (delta-9-tetrahydrocannabinol) and its metabolites as the primary active constituents, as varying the other cannabinoids tested (CBC and CBD) did not change any outcome measures.
Read More on RethinkTHC
- THC-amygdala-anxiety-brain
- anandamide-weed-withdrawal
- cannabinoid-receptors-recovery-time
- cannabis-developing-brain-teenagers
- cant-enjoy-anything-without-weed
- dopamine-recovery-after-quitting-weed
- endocannabinoid-system-explained-simply
- endocannabinoid-system-withdrawal
- nervous-system-weed-withdrawal-fight-flight
- teen-weed-use-under-18-effects-brain
- thc-brain-withdrawal
- thc-prefrontal-cortex-brain-effects
- weed-cortisol-stress-hormones
- weed-memory-loss-recovery
- weed-motivation-amotivational-syndrome
- weed-nervous-system-effects
- weed-reward-system-brain
- does-weed-expire-shelf-life-potency
- how-to-store-weed-fresh-temperature-light
- how-to-store-edibles-shelf-life-potency
- what-is-dabbing-what-does-it-do-body
- what-are-moon-rocks-why-strong
Cite This Study
https://rethinkthc.com/research/RTHC-00193APA
Ilan, A B; Gevins, A; Coleman, M; ElSohly, M A; de Wit, H. (2005). Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.. Behavioural pharmacology, 16(5-6), 487-96.
MLA
Ilan, A B, et al. "Neurophysiological and subjective profile of marijuana with varying concentrations of cannabinoids.." Behavioural pharmacology, 2005.
RethinkTHC
RethinkTHC Research Database. "Neurophysiological and subjective profile of marijuana with ..." RTHC-00193. Retrieved from https://rethinkthc.com/research/ilan-2005-neurophysiological-and-subjective-profile
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.